Add like
Add dislike
Add to saved papers

Fabrication of In 2 S 3 /Zn 2 GeO 4 composite photocatalyst for degradation of acetaminophen under visible light.

A novel indium trisulfide/zinc germinate (In2 S3 /Zn2 GeO4 ) composite was developed via a co-precipitation hydrothermal method. The as-prepared composite was characterized in detail by X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and UV-vis diffuse reflectance spectroscopy (DRS). Zn2 GeO4 nanorods work as the main photocatalyst while In2 S3 nanoparticles deposited on them acts as the photosensitizer. The resulting In2 S3 /Zn2 GeO4 heterogeneous photocatalyst not only has enhanced visible light absorption, but also improved photo-generated charge transfer efficiency with remarkably high efficiency in decomposing acetaminophen (APAP). The composite photocatalyst with the mass ratio of 30% In2 S3 showed the best activity for APAP degradation under visible light, with performance far superior to that of In2 S3 , nitrogen-doped titanium dioxide (N-TiO2 ), Degussa P25, and Zn2 GeO4 . The influences of various parameters (i.e., catalyst dosage, solution pH, and initial concentration of APAP) and background interference (humic acid (HA) and bicarbonate (HCO3 - )) on the photodegradation efficiency for APAP were also discussed. The mechanistic studies revealed that holes and superoxide radicals are mainly involved in the photodegradation of APAP by In2 S3 /Zn2 GeO4 composite. A probable reaction mechanism of APAP degradation under visible light over In2 S3 /Zn2 GeO4 heterojunction was proposed.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app